AIRLINK 193.56 Decreased By ▼ -1.27 (-0.65%)
BOP 9.95 Increased By ▲ 0.14 (1.43%)
CNERGY 7.93 Increased By ▲ 0.57 (7.74%)
FCCL 40.65 Increased By ▲ 2.07 (5.37%)
FFL 16.86 Increased By ▲ 0.41 (2.49%)
FLYNG 27.75 Increased By ▲ 0.21 (0.76%)
HUBC 132.58 Increased By ▲ 0.83 (0.63%)
HUMNL 13.89 Increased By ▲ 0.03 (0.22%)
KEL 4.60 Decreased By ▼ -0.06 (-1.29%)
KOSM 6.62 Decreased By ▼ -0.04 (-0.6%)
MLCF 47.60 Increased By ▲ 2.21 (4.87%)
OGDC 213.91 Decreased By ▼ -0.08 (-0.04%)
PACE 6.93 Increased By ▲ 0.07 (1.02%)
PAEL 41.24 Increased By ▲ 1.18 (2.95%)
PIAHCLA 17.15 Increased By ▲ 0.36 (2.14%)
PIBTL 8.41 Increased By ▲ 0.09 (1.08%)
POWER 9.64 Increased By ▲ 0.21 (2.23%)
PPL 182.35 Increased By ▲ 0.16 (0.09%)
PRL 41.96 Increased By ▲ 0.13 (0.31%)
PTC 24.90 Increased By ▲ 0.34 (1.38%)
SEARL 106.84 Increased By ▲ 4.31 (4.2%)
SILK 0.99 Decreased By ▼ -0.01 (-1%)
SSGC 40.10 Increased By ▲ 0.66 (1.67%)
SYM 17.47 Increased By ▲ 0.14 (0.81%)
TELE 8.84 Increased By ▲ 0.08 (0.91%)
TPLP 12.75 No Change ▼ 0.00 (0%)
TRG 66.95 Increased By ▲ 1.55 (2.37%)
WAVESAPP 11.33 Increased By ▲ 0.22 (1.98%)
WTL 1.79 Increased By ▲ 0.09 (5.29%)
YOUW 4.07 Increased By ▲ 0.13 (3.3%)
BR100 12,045 Increased By 70.8 (0.59%)
BR30 36,580 Increased By 433.6 (1.2%)
KSE100 114,038 Increased By 594.4 (0.52%)
KSE30 35,794 Increased By 159 (0.45%)

PARIS: Advances in bioengineering have helped repair severely damaged uteruses in rabbits through cellular tissue engineering, researchers said in a study published Monday.

The breakthrough, scientists believe, offers hope for partial reconstruction in women afflicted with so-called uterine factor infertility, which accounts for about six percent of all infertility cases.

Currently, the only way for a woman with this condition to give birth is with a transplanted uterus.

A team at Wake Forest University in North Carolina implanted biodegradable polymer scaffolds - engineered tissue partially generated from one's own cells - into damaged rabbit uteruses. Six months after implantation, the new tissue appeared no different than in non-damaged uterus, they reported in Nature Biotechnology. Furthermore, four in 10 rabbits that had received the cell-engineered tissue had normal births, while none of those who hadn't received the reparative treatment did.

"Our results introduce new avenues for potentially creating tissue substitutes derived from a patient's own cells to treat uterine defects," the authors concluded. Tissue bioengineering offers an alternative to organ transplant, which is hampered by a lack of donors and requires the recipient to take immunosuppressive drugs.

Comments

Comments are closed.